In my best Bruce Buffer voice—“ladies and gentlemen, it’s TIME!”
It's a distinct pleasure to share my recent interview with one of Redox's favorite people in health tech, Breanna Cunningham. From day one, Breanna has impressed our team with her infectious energy and amazing ability to execute. Join us as we learn about her path from trauma ICU nurse to CEO of the rapidly growing CODE Technology.
From day one, Redox has been passionate about supporting the “little guys”. So much of what we do is purposefully designed to allow anyone with a great idea or product to penetrate the healthcare market and deliver beneficial solutions to patients and providers.
What does it take to be a successful woman in healthcare technology?
With the new year fast approaching, we took some time to think about the future of healthcare and predict what significant stories we'll see play out over the next year. Join us as we gaze into our snow covered crystal ball (it’s cold here in Wisconsin) for seven bold healthcare predictions for 2017.
Donald Trump has made public his appointees for Secretary of Health and Human Services (HHS) and Administrator of the Centers for Medicare and Medicaid Services (CMS).
Ladies and gentlemen, please acquaint yourselves with six-term Republican Congressman (GA), David Price, and high flying healthcare consultant, Seema Verma.
“To the clinicians in the room, how many times has a patient looked you in the eye and said:
‘Doc, can you just give me two more weeks? I want to walk her down the aisle.’
‘Can you give me another month? He’s graduating.’
‘My daughter’s about to deliver our first grandchild, let me see it, please let me be there.’
They aren’t asking to live. They aren’t asking to be cured. They’re asking for one more moment and it matters. It matters a lot. Every damn moment counts and every moment we delay matters.”
- Joe Biden, October 24th, 2016, Cleveland Clinic Medical Innovation Summit
1 in 11 people worldwide live with diabetes. That’s over 415 million people suffering from a life-threatening disease that is also the leading cause of cardiovascular disease, blindness, kidney failure, and lower-limb amputation. While decades of research and treatment have lead to enormous improvements in both prevention and treatment, the disease, which already represents 12% of the world’s health expenditure (~$673 billion!), is growing at a frightening rate. If advancements in prevention and efficiency gains in treatment aren’t made quickly, the world risks a staggering numbers of lives lost, as well as dire financial ramifications that could threaten the stability of countries worldwide.